Xcell Therapeutics
Xcell Therapeutics Inc. is a leading company in the field of medium development that launched the world`s first GMP-grade next-generation chemically defined medium for human Mesenchymal Stem Cells (MSCs), and aims to grow into a global medium development company that meets the demands of the advanced regenerative medicine and cell-gene therapy (CGT) markets. We are expanding our pipeline of cell-specific media targeting various cells such as MSCs, exosomes, NK, and T by utilizing “cell-specific media development source technology” (XPorT: Xcell’s platform; optimized media recipe for therapeutics).
Xcell Therapeutics successfully launched and commercialized the world`s first GMP-grade chemically defined medium for MSCs, CellCor MSC CD AOF. It followed the launch of CellCor SFD MSC, a serum-free medium for MSCs.
For more information, visit: https://xcell.media
